| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,963 |
3,609 |
$374K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,767 |
1,562 |
$165K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
657 |
522 |
$72K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
633 |
578 |
$25K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
171 |
162 |
$17K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
160 |
151 |
$8K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
535 |
508 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
864 |
397 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
497 |
463 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
13 |
12 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
13 |
12 |
$1K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
15 |
12 |
$210.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
19 |
14 |
$105.00 |
| 3074F |
|
1,378 |
1,283 |
$0.00 |
| 99000 |
|
22 |
22 |
$0.00 |
| 3078F |
|
1,392 |
1,292 |
$0.00 |